Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.11
(2.49%)
CNY 4.11
(2.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 298.48 Million CNY | 67.2% |
| 2022 | 178.52 Million CNY | 130.21% |
| 2021 | -590.99 Million CNY | -345.46% |
| 2020 | 240.77 Million CNY | -26.28% |
| 2019 | 326.59 Million CNY | 201.7% |
| 2018 | -321.14 Million CNY | -197.56% |
| 2017 | 329.17 Million CNY | 28.7% |
| 2016 | 255.76 Million CNY | 228.07% |
| 2015 | 77.95 Million CNY | 44.89% |
| 2014 | 53.8 Million CNY | 24.32% |
| 2013 | 43.27 Million CNY | -55.97% |
| 2012 | 98.28 Million CNY | -11.7% |
| 2011 | 111.3 Million CNY | -23.49% |
| 2010 | 145.46 Million CNY | 37.99% |
| 2009 | 105.42 Million CNY | 94.42% |
| 2008 | 54.22 Million CNY | 810.93% |
| 2007 | 5.95 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 103.23 Million CNY | -29.63% |
| 2024 Q3 | 97.28 Million CNY | -5.76% |
| 2024 Q1 | 146.69 Million CNY | 760.7% |
| 2023 Q3 | 96.67 Million CNY | 13.79% |
| 2023 Q1 | 99.81 Million CNY | 177.4% |
| 2023 FY | 298.48 Million CNY | 67.2% |
| 2023 Q4 | 17.04 Million CNY | -82.37% |
| 2023 Q2 | 84.95 Million CNY | -14.88% |
| 2022 Q1 | 39.43 Million CNY | 105.0% |
| 2022 Q4 | 35.98 Million CNY | -32.09% |
| 2022 Q2 | 50.12 Million CNY | 27.13% |
| 2022 FY | 178.52 Million CNY | 130.21% |
| 2022 Q3 | 52.98 Million CNY | 5.69% |
| 2021 Q1 | 68.68 Million CNY | 516.93% |
| 2021 Q3 | 79.75 Million CNY | 60.42% |
| 2021 Q4 | -789.15 Million CNY | -1089.52% |
| 2021 FY | -590.99 Million CNY | -345.46% |
| 2021 Q2 | 49.71 Million CNY | -27.62% |
| 2020 Q4 | 11.13 Million CNY | -85.14% |
| 2020 Q3 | 74.94 Million CNY | -3.58% |
| 2020 Q2 | 77.72 Million CNY | 0.98% |
| 2020 Q1 | 76.97 Million CNY | 21.45% |
| 2020 FY | 240.77 Million CNY | -26.28% |
| 2019 FY | 326.59 Million CNY | 201.7% |
| 2019 Q4 | 63.37 Million CNY | -25.47% |
| 2019 Q3 | 85.03 Million CNY | -7.32% |
| 2019 Q2 | 91.75 Million CNY | 6.17% |
| 2019 Q1 | 86.42 Million CNY | 114.79% |
| 2018 Q3 | 65.03 Million CNY | -30.74% |
| 2018 FY | -321.14 Million CNY | -197.56% |
| 2018 Q1 | 104.26 Million CNY | 186.16% |
| 2018 Q2 | 93.9 Million CNY | -9.94% |
| 2018 Q4 | -584.34 Million CNY | -998.53% |
| 2017 FY | 329.17 Million CNY | 28.7% |
| 2017 Q2 | 123.27 Million CNY | 18.06% |
| 2017 Q4 | 36.43 Million CNY | -43.98% |
| 2017 Q1 | 104.41 Million CNY | 44.92% |
| 2017 Q3 | 65.04 Million CNY | -47.24% |
| 2016 Q3 | 84.87 Million CNY | 33.73% |
| 2016 FY | 255.76 Million CNY | 228.07% |
| 2016 Q4 | 72.05 Million CNY | -15.11% |
| 2016 Q2 | 63.46 Million CNY | 79.48% |
| 2016 Q1 | 35.36 Million CNY | 145.38% |
| 2015 Q1 | 10.7 Million CNY | 51.47% |
| 2015 Q3 | 30.38 Million CNY | 35.33% |
| 2015 FY | 77.95 Million CNY | 44.89% |
| 2015 Q4 | 14.41 Million CNY | -52.57% |
| 2015 Q2 | 22.45 Million CNY | 109.66% |
| 2014 Q4 | 7.07 Million CNY | -12.99% |
| 2014 FY | 53.8 Million CNY | 24.32% |
| 2014 Q1 | 18.65 Million CNY | 60.42% |
| 2014 Q2 | 19.95 Million CNY | 6.94% |
| 2014 Q3 | 8.12 Million CNY | -59.27% |
| 2013 Q4 | 11.62 Million CNY | 74.12% |
| 2013 FY | 43.27 Million CNY | -55.97% |
| 2013 Q1 | 17.47 Million CNY | 54.69% |
| 2013 Q2 | 7.49 Million CNY | -57.1% |
| 2013 Q3 | 6.67 Million CNY | -10.9% |
| 2012 FY | 98.28 Million CNY | -11.7% |
| 2012 Q3 | 26.59 Million CNY | -19.67% |
| 2012 Q1 | 27.28 Million CNY | 89.01% |
| 2012 Q4 | 11.29 Million CNY | -57.53% |
| 2012 Q2 | 33.1 Million CNY | 21.31% |
| 2011 Q3 | 19.27 Million CNY | -49.13% |
| 2011 Q4 | 14.43 Million CNY | -25.1% |
| 2011 Q2 | 37.89 Million CNY | -4.55% |
| 2011 FY | 111.3 Million CNY | -23.49% |
| 2011 Q1 | 39.69 Million CNY | 12.36% |
| 2010 Q2 | 35.98 Million CNY | -6.55% |
| 2010 Q1 | 38.5 Million CNY | 0.0% |
| 2010 Q4 | 35.33 Million CNY | -0.91% |
| 2010 Q3 | 35.65 Million CNY | -0.9% |
| 2010 FY | 145.46 Million CNY | 37.99% |
| 2009 FY | 105.42 Million CNY | 94.42% |
| 2008 FY | 54.22 Million CNY | 810.93% |
| 2007 FY | 5.95 Million CNY | 0.0% |